These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12860580)

  • 1. Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure: a dose-related adverse effect of aspirin.
    Guazzi M; Brambilla R; Reina G; Tumminello G; Guazzi MD
    Arch Intern Med; 2003 Jul; 163(13):1574-9. PubMed ID: 12860580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
    McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
    Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    Levy PD; Nandyal D; Welch RD; Sun JL; Pieper K; Ghali JK; Fonarow GC; Gheorghiade M; O'Connor CM
    Am Heart J; 2010 Feb; 159(2):222-230.e2. PubMed ID: 20152220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
    Mahmood SA; Hussein GM; Hamza EA
    Saudi Med J; 2004 Aug; 25(8):1060-5. PubMed ID: 15322598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibitors prescription is associated with longer survival among patients hospitalized for congestive heart failure who have preserved systolic function: a long-term follow-up study.
    Grigorian Shamagian L; Roman AV; Ramos PM; Veloso PR; Bandin Dieguez MA; Gonzalez-Juanatey JR
    J Card Fail; 2006 Mar; 12(2):128-33. PubMed ID: 16520261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining aspirin with angiotensin converting enzyme inhibitors in heart failure: how safe is it?
    Mehta H; Mahajan A; Bansal N; Vaidya S; Pathak L
    J Assoc Physicians India; 1998 Nov; 46(11):953-6. PubMed ID: 11229224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.
    Rydén L; Armstrong PW; Cleland JG; Horowitz JD; Massie BM; Packer M; Poole-Wilson PA
    Eur Heart J; 2000 Dec; 21(23):1967-78. PubMed ID: 11071803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
    Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
    J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
    J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A propensity score analysis of the impact of angiotensin-converting enzyme inhibitors on long-term survival of older adults with heart failure and perceived contraindications.
    Ahmed A; Centor RM; Weaver MT; Perry GJ
    Am Heart J; 2005 Apr; 149(4):737-43. PubMed ID: 15990761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
    Song HM; Zhang J; Deng B; Luo M
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors.
    Fisman EZ; Grossman E; Motro M; Tenenbaum A
    J Hum Hypertens; 2002 Jun; 16(6):379-83. PubMed ID: 12037691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aspirin, angiotensin converting enzyme inhibitors and cardiac insufficiency].
    de Groote P; Aumégeat V; Meurice T; Millaire A; Lamblin N; Lablanche JM
    Arch Mal Coeur Vaiss; 2000 Feb; 93(2):167-71. PubMed ID: 10830093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R; Rosenson RS; Fernandes AW; Khan M; Murray FT
    Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between serum sodium levels and prognosis in outpatients with chronic heart failure: neutral effect of treatment with beta-blockers and angiotensin-converting enzyme inhibitors: data from the Italian Network on Congestive Heart Failure (IN-CHF database).
    Baldasseroni S; Urso R; Orso F; Bianchini BP; Carbonieri E; Cirò A; Gonzini L; Leonardi G; Marchionni N; Maggioni AP;
    J Cardiovasc Med (Hagerstown); 2011 Oct; 12(10):723-31. PubMed ID: 21873881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.